期刊文献+

β淀粉样蛋白处理大鼠认知和微量营养素状况的变化

Changes of cognition and micronutrient levels in rats treated by β amyloid protein
下载PDF
导出
摘要 目的观察认知功能损伤大鼠体内几种主要维生素和微量元素含量的改变。方法30只雄性SD大鼠随机分为正常对照组、β淀粉样蛋白(Aβ)组和生理盐水组,每组10只。正常对照组不作任何处理,Aβ组双侧海马内注射Aβ(每侧10μg),生理盐水组海马内注射等体积生理盐水。实验周期两周。通过水迷宫试验、避暗试验检测大鼠认知功能;采用原子吸收分光光度法、微量荧光法等方法检测动物血清维生素A、维生素E、维生素C、维生素B2、维生素B6、叶酸及微量元素铜、锌、铁的含量。结果海马内注射Aβ使大鼠认知功能有下降趋势;与正常对照组及生理盐水组比较,Aβ组大鼠水迷宫试验及避暗试验潜伏期均延长,且血清维生素C及铁含量明显下降(P<0.05);各组大鼠其余指标差异均无显著性。结论海马内注射Aβ可导致大鼠认知功能损伤以及血清维生素C、铁含量降低。 Objective To observe the changes of the cognition and micronutrient level in rats treated by β amyloid protein. Methods Thirty male Sprague-Dawley rats were randomly divided into control group, β amyloid group(Aβ) and saline group. The rats were injected Aβ and saline by bilateral intrahippocampus(10μg per lateral)in Aβ group and saline group separately. The experiment lasted 2 weeks. The cognition was identified by water maze and step through test. The contents of serum micronutrients were examined by atomic absorption spectrometry and fluorescence spectrometry. Results Declined cognition and prolonged latency were observed in Aβ group. The contents of serum vitamin C and iron in Aβ group were significantly lower than those of the control group and saline group( P 〈 0.05) . There was no significant difference among the three groups in other indicators. Conclusion It was seemed that impaired cognition and decreases of serum vitamin C and iron level could be observed in rats treated by β amyloid protein.
出处 《卫生研究》 CAS CSCD 北大核心 2007年第1期43-45,共3页 Journal of Hygiene Research
基金 中国营养学会2004年度"营养科研基金"项目
关键词 认知 微量营养素 Β淀粉样蛋白 cognition, micronutrient, β amyloid protein
  • 相关文献

参考文献4

二级参考文献14

  • 1赵志炜,程浩然,刘梦霞,李子中,王蓉,姬志娟,李生海,盛树力.李氏5号方水提液对D-半乳糖老化小鼠海马神经元凋亡级联反应的影响[J].中国临床康复,2004,8(22):4546-4547. 被引量:1
  • 2邓利芝,万新红,冯欣蘅,李炯,林小荣,陈金龙,黄建明.厄贝沙坦对大鼠心肌细胞凋亡及Bcl-2/Bax蛋白表达的影响[J].中国临床康复,2004,8(24):4998-5000. 被引量:1
  • 3徐庆中 卢德宏 董彬.Alzheimer''s型老年性痴呆的神经病理学[A].盛树力主编.老年性痴呆.从分子生物学到临床诊治[M].2版[C].北京:科学技术文献出版社,1998.79-80.
  • 4Zhu H,Fu W. The catalytic subunit of telomerase protects neurons against amyloid beta peptide induced apoptosis. Neurochem 2000;75(1): 117 -24.
  • 5Giovannelli L,Gasamenti F,Scall C,et al. Differential effect of amyloid peptideβ-(1 -40) and β-(25-35) injection into the rat nucleus basalis. Neuroscience1995; 66:781 -2.
  • 6Megan JM,Teresa GI,Bradley TH. Apolipoprotein E genotype and deposits of Aβ1 -42 and Aβ1-42 in Alzheimer disease. Arch Neurol 1998; 55:1001 -4.
  • 7Busciglio J,Lorenzo A,Yanker BA,et al. Methodological variables in the assessment of β-amyloid neurotoxicity. Neurobiol Aging 1992; 13:609 - 12.
  • 8Forloni G,Tagliavini F,Bugiani O,et al. Amyloid in Alzheimer' s disease and prion-related encephalopathies: studies with synathetic peptides. Prog Neurobiol1996; 49; 287 - 315.
  • 9De Leon MJ,George AE,Stylopulos LA,et al. Early marker for Alzheimer' s disease: the atrophic hippocampus. Lancet 1989; 2:672 -5.
  • 10Li WP,Chan WY,Lai HW,et al. Terminal Dutp nick end labeling(TUNEL)positive cells in the different regions of the bran in normal aging and Alzheimer patient. Mol Neurosci 1997; 8: 75 - 82.

共引文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部